Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,787 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.
Cunniffe N, Vuong KA, Ainslie D, Baker D, Beveridge J, Bickley S, Camilleri P, Craner M, Fitzgerald D, de la Fuente AG, Giovannoni G, Gray E, Hazlehurst L, Kapoor R, Kaur R, Kozlowski D, Lumicisi B, Mahad D, Neumann B, Palmer A, Peruzzotti-Jametti L, Pluchino S, Robertson J, Rothaul A, Shellard L, Smith KJ, Wilkins A, Williams A, Coles A. Cunniffe N, et al. Among authors: fitzgerald d. J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):295-302. doi: 10.1136/jnnp-2020-324286. Epub 2020 Nov 12. J Neurol Neurosurg Psychiatry. 2021. PMID: 33184094
In vitro and ex vivo models of multiple sclerosis.
Madill M, Fitzgerald D, O'Connell KE, Dev KK, Shen S, FitzGerald U. Madill M, et al. Among authors: fitzgerald u, fitzgerald d. Drug Discov Today. 2016 Sep;21(9):1504-1511. doi: 10.1016/j.drudis.2016.05.018. Epub 2016 Jun 3. Drug Discov Today. 2016. PMID: 27265771 Review.
Reduced Cone Density Is Associated with Multiple Sclerosis.
McIlwaine G, Csincsik L, Coey R, Wang L, Fitzgerald D, Moffat J, Dubis AM, McDonnell G, Hughes S, Peto T, Lengyel I. McIlwaine G, et al. Among authors: fitzgerald d. Ophthalmol Sci. 2023 Apr 13;3(3):100308. doi: 10.1016/j.xops.2023.100308. eCollection 2023 Sep. Ophthalmol Sci. 2023. PMID: 37214765 Free PMC article.
Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis.
Evans R, Watkins LM, Hawkins K, Santiago G, Demetriou C, Naughton M, Dittmer M, Rees MI, Fitzgerald D, Morgan BP, Neal JW, Howell OW. Evans R, et al. Among authors: fitzgerald d. Front Cell Neurosci. 2023 Mar 22;17:1094106. doi: 10.3389/fncel.2023.1094106. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37032838 Free PMC article.
Research priorities for neuroimmunology: identifying the key research questions to be addressed by 2030.
MacKenzie G, Subramaniam S, Caldwell LJ, Fitzgerald D, Harrison NA, Hong S, Irani SR, Khandaker GM, Liston A, Miron VE, Mondelli V, Morgan BP, Pariante C, Shah DK, Taams LS, Teeling JL, Upthegrove R. MacKenzie G, et al. Among authors: fitzgerald d. Wellcome Open Res. 2021 Jul 29;6:194. doi: 10.12688/wellcomeopenres.16997.1. eCollection 2021. Wellcome Open Res. 2021. PMID: 34778569 Free PMC article.
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
Ortega MC, Lebrón-Galán R, Machín-Díaz I, Naughton M, Pérez-Molina I, García-Arocha J, Garcia-Dominguez JM, Goicoechea-Briceño H, Vila-Del Sol V, Quintanero-Casero V, García-Montero R, Galán V, Calahorra L, Camacho-Toledano C, Martínez-Ginés ML, Fitzgerald DC, Clemente D. Ortega MC, et al. Among authors: fitzgerald dc. Acta Neuropathol. 2023 Aug;146(2):263-282. doi: 10.1007/s00401-023-02593-x. Epub 2023 May 27. Acta Neuropathol. 2023. PMID: 37243699 Free PMC article.
Brain regulatory T cells.
Liston A, Pasciuto E, Fitzgerald DC, Yshii L. Liston A, et al. Nat Rev Immunol. 2024 May;24(5):326-337. doi: 10.1038/s41577-023-00960-z. Epub 2023 Dec 1. Nat Rev Immunol. 2024. PMID: 38040953 Review.
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.
Skorupan N, Peer CJ, Zhang X, Choo-Wosoba H, Ahmad MI, Lee MJ, Rastogi S, Sato N, Yu Y, Pegna GJ, Steinberg SM, Kalsi SS, Cao L, Figg WD, Trepel JB, Pastan I, FitzGerald D, Alewine C. Skorupan N, et al. Among authors: fitzgerald d. Front Oncol. 2024 Apr 19;14:1386190. doi: 10.3389/fonc.2024.1386190. eCollection 2024. Front Oncol. 2024. PMID: 38706610 Free PMC article.
1,787 results